March 11, 2026

Automated screening and education increase urinary incontinence diagnoses

March 11, 2026 / Clinical Practice / InnovateMed Author / urinary incontinenece

by Melissa Rohman, Northwestern University edited by Lisa Lock, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain Implementing an automated urinary incontinence screening and education program in primary care practices significantly increased awareness and treatment referrals in women with the condition, according to a recent study published in JAMA Internal Medicine. Urinary incontinence […]

Automated screening and education increase urinary incontinence diagnoses Read More »

Simple test could transform time to endometriosis diagnosis

March 11, 2026 / Clinical Practice / InnovateMed Author / endometriosis

by University of Queensland edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain A simple five-minute test addressing major endometriosis diagnostic delays and treatment, has been developed by University of Queensland researchers. The Simplified Adolescent Factors for Endometriosis (SAFE) score uses a questionnaire to identify at-risk patients

Simple test could transform time to endometriosis diagnosis Read More »

Experimental vaccine could help turn the tide on America’s opioid epidemic

March 11, 2026 / Research update / InnovateMed Author / opioid

by Briana Bittner, Virginia Tech edited by Lisa Lock, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Credit: Journal of Controlled Release (2025). DOI: 10.1016/j.jconrel.2025.114294 Virginia Tech researchers are advancing a new generation of vaccines designed to block opioids from reaching the brain and triggering their addictive effects, work that could help prevent overdose deaths that

Experimental vaccine could help turn the tide on America’s opioid epidemic Read More »

Focused ultrasound subtly primes human brain to respond, EEG study finds

March 11, 2026 / Research update / InnovateMed Author / EGG

by Sara Pecchia, Carnegie Mellon University edited by Robert Egan Editors’ notes The GIST Add as preferred source A) The experiment consisted of applying neuromodulation to eyes-closed resting-state humans. B) A diagram of the experimental set up for each condition is provided with tDCS electrodes and ultrasound transducers placed on their relative location to EEG electrodes. C)

Focused ultrasound subtly primes human brain to respond, EEG study finds Read More »

FDA finds little evidence that a generic drug can help people with autism

March 11, 2026 / Clinical Practice / InnovateMed Author / autism

by Matthew Perrone edited by Andrew Zinin Editors’ notes The GIST Add as preferred source President Donald Trump listens as Dr. Marty Makary, commissioner of the Food and Drug Administration, speaks in the Roosevelt Room of the White House, Monday, Sept. 22, 2025, in Washington. Credit: AP Photo/Mark Schiefelbein, file The Food and Drug Administration on

FDA finds little evidence that a generic drug can help people with autism Read More »

Wegovy may have highest ‘eye stroke’ and sight loss risk among semaglutide GLP-1 agonists

March 11, 2026 / Research update / InnovateMed Author / GLP 1 angonist

by British Medical Journal edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of “eye stroke” (ischemic optic neuropathy) and sudden sight loss of the semaglutide drugs, finds an analysis of unintended side effect reports

Wegovy may have highest ‘eye stroke’ and sight loss risk among semaglutide GLP-1 agonists Read More »

Scientists develop two-vaccine strategy to fight T cell lymphoma

March 11, 2026 / Research update / InnovateMed Author / T cell lymphoma

by Darien Sutton, The Wistar Institute edited by Robert Egan, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Wistar Institute’s Dr. David Weiner (center) in the lab. Credit: The Wistar Institute T cell lymphomas are notoriously difficult to treat because immunotherapy, despite being one of the most effective therapies for treating cancer, can’t easily

Scientists develop two-vaccine strategy to fight T cell lymphoma Read More »

Clotting protein presents a potential target in pancreatic cancer

March 11, 2026 / Research update / InnovateMed Author / pancreatic cancer

by Candace Gwaltney, Indiana University edited by Robert Egan Editors’ notes The GIST Add as preferred source Melissa Fishel’s lab found that depleting a clotting protein made by the liver could slow down pancreatic cancer. Credit: Tim Yates, IU School of Medicine Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have found that

Clotting protein presents a potential target in pancreatic cancer Read More »

Hotter days, heavier minds: What climate change could mean for US mental health

March 11, 2026 / Clinical Practice / InnovateMed Author / climate

by George Washington University edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain Climate change is widely known to affect physical health—but new research suggests the mental health toll could be enormous. A study published in The Lancet Planetary Health projects that rising temperatures could lead to hundreds of

Hotter days, heavier minds: What climate change could mean for US mental health Read More »

Approved IV drug reduces lupus symptoms, clinical trial finds

March 11, 2026 / Clinical Practice / InnovateMed Author / lupus

by Dennis Thompson edited by Sadie Harley, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source An already-approved IV drug significantly reduces the symptoms of lupus, a new clinical trial showed. More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant improvement in their symptoms after a year on the drug, researchers

Approved IV drug reduces lupus symptoms, clinical trial finds Read More »